Small Molecule Prefilled Syringes Market, by Drug Class (Cardiovascular Drugs, Neurology Drugs, Analgesics, Adjuvants, and Others), By Material (Glass, and Plastic & Polymer) and Region - Global Trends and Forecast to 2025
- Report code : CMI61629 |
- Industry :
Pharmaceutical
- Published On : May 2018 |
- Pages : 161 Pages |
- Format :
- Request Sample
- Request Customization
Small Molecule Prefilled Syringes Market Insights
Small molecule prefilled syringes are pharmaceutical preparations of small molecule drugs that are sold in prefilled syringes. Small molecule prefilled syringes are alternatives to other dosage forms such as tablets and capsules. Empty glass or plastic and polymer syringes are filled with the solution of the active pharmaceutical ingredients. Drugs belonging to categories such as cardiovascular, analgesics, neurology, and adjuvants are offered in prefilled syringe delivery systems. Small molecule prefilled syringes have faster therapeutic action as compared to tablets and capsules, as drug directly enters into the bloodstream. Moreover, self-administration can be done with the help of these products, which is convenient for the patients. Rising incidence of chronic diseases such as cancer and cardiovascular diseases is expected to be factor for growth of the small molecule prefilled syringes market. Prefilled syringe is a novel drug delivery system, which offers many advantages over other dosage forms. Prefilled syringes have fixed dosage, which avoids issues such as dosage errors, reduced incidences of needle-stick injuries due to innovative lock technologies, and needleless syringes. Manufacturers such as Becton, Dickinson and Company, and Pfizer, Inc. offer innovative prefilled syringe products.
Development of technologically advanced prefilled syringes is expected to boost demand for small molecule prefilled syringes
Manufacturers are engaged in development of dual or multi-chambered prefilled syringes (AL Biosciences, Inc. manufacturers multi-chambered prefilled syringe), which have various applications in areas such as reconstituted drugs and other potent drugs (for instant therapeutic action). These also offer convenience to end users. Furthermore, technological advancements in design and manufacturing of prefilled syringes have also aided pharmaceutical players to commercialize various drugs into prefilled dosage forms such as Penicillin. Several pharmaceutical players have developed prefilled syringes containing active pharmaceutical ingredients, which has aided these players in increasing their revenues. For instance, Teva Pharmaceutical Industries Ltd. earned significant revenues from the sale of its drug Copaxone in 2016, which comes in a prefilled syringe. Manufacturers of prefilled syringe have developed innovative prefilled syringes and dual- and multi-chambered syringes for sensitive drugs to avoid reactions. The drug chamber is separated with diluent chamber with a barrel in between the two chambers and the barrel serves as a barrier between two chambers. For instance, Pfizer, Inc. has iSecure one piece prefilled syringe without needle. iSecure is a one- piece, needle-free technology which helps in minimizing needle-stick injuries.
The global small molecule prefilled syringes market was valued at US$ 13,749.4 million in 2016 and is expected to witness a robust CAGR of 4.6% over the forecast period (2017–2025).
Figure 1. Global Small Molecule Prefilled Syringes Market Share (%), by Material Type 2017 and 2025
Source: Coherent Market Insights Analysis (2017)
Increasing adoption of self-injection devices is expected to foster growth of the small molecule prefilled syringes market
Effectiveness of drug delivery mainly depends on route of administration. Parenteral are highly preferred and commonly used route of drug administration. The recent past has witnessed significant growth in advanced drug delivery devices, due to development and easy availability of parenteral drugs. Main benefits of prefilled syringes over conventional drug delivery systems is improved product safety, self-administration, accurate dosing, and low chances of drug contamination. Self-injection advantage of prefilled syringes is a major factor for increasing adoption of these, thus aiding in growth of the prefilled syringe market globally. Apart from these aforementioned benefits, dual-chamber prefilled syringe may be useful with reconstituted drugs, which would help in avoiding wastage of drugs and overdose. Major pharmaceutical companies are focusing on advancing the use of self-administration devices globally. In 2015, SCHOTT launched a prefillable syringe design—SCHOTT TopPac. These SD polymer prefillable syringes minimize the risk between sensitive drugs and packaging container.
However, factors such as complex manufacturing process, high costs, and requirement of high quality of these products (responsible for high costs) are expected to hinder growth of the market over the forecast period.
Some major players operating in the small molecule prefilled syringes market include Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, and Fresenius Kabi AG.
Prefilled syringes are specialized formulation consisting of either small molecules or large molecules. The final costs of these products are a combination of the price of drug formulation as well as syringe component. Significant amount of research and development is necessary to bring these products in the market, which results in prices being higher, as specialized drug delivery systems are utilized. In some countries such as the U.S., Canada, and Australia, the medicinal products that are sold in prefilled syringes are termed as combination products. Regulatory scenario for the combination products has been properly defined in the U.S. and Canada. However, in other regions such as Europe and Asia Pacific the regulations for combination products have not been properly defined. U.S. FDA regulates these products as combination products.
Market Dynamics
Major drugs in the neurology drugs segment such as Copaxone (manufactured by Teva Pharmaceutical Industries Ltd.) are expected to face competition from generics. Manufacturers such as Schott AG are involved in prefilled syringe product innovation, in order to improve medical outcomes, which compliments growth of the small molecule prefilled syringe market. The market is expected to exhibit significant growth, owing to increasing adoption of technologically advanced prefilled syringes such as Schott TopPac. Advantages offered by prefilled syringes such as accurate dosage, and instant therapeutic effect over conventional products such as tablets and capsules is expected to foster growth of small molecule prefilled syringes market.
Key features of the study:
- This report provides in-depth analysis of small molecule prefilled syringes market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global small molecule prefilled syringes market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key companies covered as a part of this study include Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, and Fresenius Kabi AG
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global small molecule prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the small molecule prefilled syringes market
Detailed Segmentation:
- Global Small Molecule Prefilled Syringes Market, by Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- Global Small Molecule Prefilled Syringes Market, by Material Type:
- Glass
- Plastic & Polymer
- Global Small Molecule Prefilled Syringes Market, by Region:
- North America
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Country:
- U.S.
- Canada
- Europe
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Country:
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Country:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Pfizer, Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Sanofi S.A.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Becton, Dickinson, and Company
- Fresenius Kabi AG
- Pfizer, Inc.*
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Material Type
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- PORTER’s Analysis
- Regulatory Scenario
- Global Small Molecule Prefilled Syringes Market, By Drug Class, 2015–2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Cardiovascular Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Neurology Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Global Small Molecule Prefilled Syringes Market, By Material Type, 2015–2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Glass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Plastic & Polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Global Small Molecule Prefilled Syringes Market, By Regions, 2015–2025 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, For Regions, 2016–2025
- Regional Trends
- North America
- Market Size and Forecast, By Drug Class, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Material Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Class, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Material Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Class, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Material Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of APAC
- Latin America
- Market Size and Forecast, By Drug Class, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Material Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Drug Class, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Material Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Drug Class, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Material Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Competitive Landscape
- Company Profiles
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson, and Company
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Kabi AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 34 market data tables and 55 figures on "Small Molecule Prefilled Syringes Market - Global forecast to 2025”.
Research Methodology
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
- Primary Research (Trade Surveys and Experts Interviews)
- Desk Research
- Proprietor Data Analytics Model
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
- National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
- Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
- Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
- Trade association, National and international media and trade press.
- Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
- Scientific journals, and other technical magazines and whitepapers.
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Data Standardization:
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
- Micro-economic indicators
- Macro-economic indicators
- Environmental indicators
- Socio-political indicators
- Technology indicators
Data Processing
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
Data Validation
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
- It provides first-hand information on the market dynamics, outlook, and growth parameters.
- Industry experts validates the estimates which helps the company to cement the on-going research study.
- Primary research includes online surveys, face-to face interviews, and telephonic interviews.
The primary research is conducted with the ecosystem players including, but not limited to:
- Raw Material Suppliers
- Manufacturers
- System Integrators
- Distributors
- End-users
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.